BeiGene Market Cap

BeiGene has a market cap or net worth of 196.20 billion as of May 12, 2025. Its market cap has increased by 61.45% in one year.

Market Cap

196.20B

Enterprise Value

184.36B

Revenue

32.49B

Ranking

n/a

PE Ratio

n/a

Stock Price

134.10

Market Cap Chart

Since February 3, 2016, BeiGene's market cap has increased from 6.70B to 196.20B, an increase of 2,829.70%. That is a compound annual growth rate of 43.92%.

Market Cap History

Date	Market Cap	% Change
May 12, 2025	196.20B	28.43%
Dec 31, 2024	152.77B	4.09%
Dec 29, 2023	146.76B	-17.60%
Dec 30, 2022	178.11B	-17.96%
Dec 31, 2021	217.12B	19.19%
Dec 31, 2020	182.15B	130.77%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Hansoh Pharmaceutical Group Company	140.92B
JD Health International	117.99B
WuXi Biologics	93.82B
Innovent Biologics	86.36B
Alibaba Health Information Technology	80.09B
Akeso	75.71B
Sichuan Kelun-Biotech Biopharmaceutical	71.46B
Sino Biopharmaceutical	69.96B

Market Cap Rankings